{"nct_id":"NCT01137682","title":"Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly","status":"COMPLETED","status_verified_date":"2018-04","start_date":"2010-07-19","start_date_type":"ACTUAL","primary_completion_date":"2013-01-22","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}